Diagnostic and Biotech

Hospital-acquired infection Diagnostics Market by Product (Instrument and Reagents and Consumables) by Test Type (Molecular Diagnostics, Urinalysis, and Immunoassay) by Application (Disease Testing and Drug-Resistance Testing), by Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others) and by End User (Hospital, Clinics, Ambulatory Surgery Centres (ASC) and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL1669210
  • 140 Pages
  • September 2017
  • Diagnostic and Biotech

Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others. Based on end user this market is segmented into hospital, clinics, ambulatory surgery centres (ASC) and others. By region, the market is analysed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global hospital-acquired infections market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

  • Instrument and Reagents
  • Consumables

By Test Type

  • Molecular Diagnostics
  • Urinalysis
  • Immunoassay

By Application

  • Disease Testing and
  • Drug-Resistance Testing

By Infection Type

  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others

End User

  • Hospital
  • Clinics
  • Ambulatory Surgery Centers (ASC)
  • Others

BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Abbott Laboratories
  • AdvanDX
  • Alere Inc.
  • AstraZeneca plc
  • Bayer Schering Pharma LLC
  • Becton Dickinson & Company
  • Cepheid Inc.
  • Roche AG
  • Daiichi Sankyo
  • Hologic, Inc.

The other players in the value chain include (profiles not included in the report)

  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co.
  • Meridien
  • Pfizer
  • Seegene
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017 | $3390 | Pre Book Price:$2967

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

July 2017 | $5370 | Pre Book Price:$4699

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

July 2017 | $5370 | Pre Book Price:$4699

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017 | $5370 | Pre Book Price:$4699

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

July 2017 | $3390 | Pre Book Price:$2967

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

July 2017 | $5370 | Pre Book Price:$4699

2017 © Copyright Big Market Research

View Pricing >>